Target intelligence / Profile preview

Cellular debris

Molecular classification
Other, Biological material, Damage-associated molecular patterns (DAMPs)
01

Overview

Cellular debris refers to the heterogeneous collection of apoptotic and necrotic remnants, including cell fragments, proteins, lipids, and nucleic acids, that are generated following cell death. In a therapeutic context, particularly in oncology, "debris" is recognized as a potent driver of tumor progression and metastasis through a process known as the Révész effect, where therapy-induced dead cells trigger a pro-inflammatory cytokine storm that stimulates the growth of surviving cancer cells. In neurodegenerative conditions such as multiple sclerosis and Alzheimer's disease, the accumulation of myelin and amyloid debris inhibits tissue repair and promotes chronic neuroinflammation. Therapeutic strategies targeting debris involve stimulating its clearance by phagocytic cells (efferocytosis) using specialized pro-resolving mediators (SPMs) like resolvins or inhibiting the downstream inflammatory signaling pathways triggered by debris components, such as the sEH and EP4 receptor pathways. This approach aims to improve the efficacy of cytotoxic treatments and prevent disease recurrence or secondary injury by resolving the inflammatory microenvironment.

Other names
Cell debrisNecrotic debrisApoptotic debrisMyelin debrisTumor cell debrisBiological debris
02

Biological functions

Inducing inflammationStimulating tumor repopulation (Révész effect)Inhibiting remyelinationTriggering cytokine stormsSignaling via damage-associated molecular patterns (DAMPs)
03

Disease associations

CancerNeurodegenerative diseaseMultiple sclerosisAlzheimer's diseaseInflammationOsteolysis
04

Safety considerations

Potential for non-specific immunosuppressionComplex and variable composition makes targeted clearance difficultRisk of incomplete clearance leading to chronic auto-inflammation
05

Interacting drugs

Resolvin D1

5 more in the full profile.

06

Biomarkers

High mobility group box 1 (HMGB1)Cell-free DNA (cfDNA)Circulating histonesPhosphatidylserine exposureSoluble epoxide hydrolase (sEH) levels

Beyond the preview

Go deeper on Cellular debris.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular debris.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call